Abstract:In our continuing efforts to develop novel c-Met inhibitors as potential anticancer candidates, a series of new N-sulfonylamidine derivatives were designed, synthesized via Cu-catalyzed multicomponent reaction (MCR) as the key step, and evaluated for their in vitro biological activities against c-Met kinase and four cancer cell lines (A549, HT-29, MKN-45 and MDA-MB-231). Most of the target compounds showed moderate to significant potency at both the enzyme-based and cell-based assay and possessed selectivity for A549 and HT-29 cancer cell lines. The preliminary SAR studies demonstrated that compound 26af (c-Met IC50 = 2.89 nM) was the most promising compound compared with the positive foretinib, which exhibited the remarkable antiproliferative activities, with IC50 values ranging from 0.28 to 0.72 μM. Mechanistic studies of 26af showed the anticancer activity was closely related to the blocking phosphorylation of c-Met, leading to cell cycle arresting at G2/M phase and apoptosis of A549 cells by a concentration-dependent manner. The promising compound 26af was further identified as a relatively selective inhibitor of c-Met kinase, which also possessed an acceptable safety profile and favorable pharmacokinetic properties in BALB/c mouse. The favorable drug-likeness of 26af suggested that N-sulfonylamidines may be used as a promising scaffold for antitumor drug development. Additionally, the docking study and molecular dynamics simulations of 26af revealed a common mode of interaction with the binding site of c-Met. These positive results indicated that compound 26af is a potential anti-cancer candidate for clinical trials, and deserves further development as a selective c-Met inhibitor.

Synthesis and antimetastatic effects of E-salignone amide derivatives

Synthesis and Antimetastatic Effect of E-salignone

Design and Synthesis of Novel Dehydroepiandrosterone Analogues As Potent Antiproliferative Agents

Synthesis and anti-metastatic effects of novel chiral ionone alkaloid derivatives

Synthesis and anti-metastatic effects of pregn-17(20)-en-3-amine derivatives.

Antitumor Agents 295. E-ring Hydroxylated Antofine and Cryptopleurine Analogues As Antiproliferative Agents: Design, Synthesis, and Mechanistic Studies.

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis and Evaluation of Sulfonamide Derivatives Targeting EGFR790M/L858R Mutations and ALK Rearrangement As Anticancer Agents.

Synthesis and Antitumor Activity of Dehydroepiandrosterone Derivatives on Es-2, A549, and Hepg2 Cells in Vitro

Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma

Synthesis and bioevaluation of novel steroidal isatin conjugates derived from epiandrosterone/androsterone

Synthesis and Biological Activity of Novel Organoselenium Derivatives Targeting Multiple Kinases and Capable of Inhibiting Cancer Progression to Metastases

Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of tumor growth and tumor angiogenesis of mouse ehrlich ascites tumor in vivo

Design, synthesis and biological evaluation of novel <i>N</i>-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction

Discovery and biological evaluation of pregnenolone selenocyanoamides with potential anticancer and antimicrobial activities

Synthesis and Biological Evaluation of Novel Anthranilamide Derivatives As Anticancer Agents

Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction

Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents.

Synthesis and biological activity evaluation of emodin quaternary ammonium salt derivatives as potential anticancer agents

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents